Bank of New York Mellon’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.4M Buy
388,082
+11,219
+3% +$620K ﹤0.01% 1473
2025
Q1
$18.2M Sell
376,863
-13,925
-4% -$673K ﹤0.01% 1548
2024
Q4
$15.1M Buy
390,788
+34,455
+10% +$1.33M ﹤0.01% 1717
2024
Q3
$16M Buy
356,333
+152,034
+74% +$6.84M ﹤0.01% 1698
2024
Q2
$7.08M Buy
204,299
+17,065
+9% +$591K ﹤0.01% 2148
2024
Q1
$5.42M Sell
187,234
-15,943
-8% -$461K ﹤0.01% 2283
2023
Q4
$4.66M Buy
203,177
+1,733
+0.9% +$39.7K ﹤0.01% 2399
2023
Q3
$3.36M Buy
201,444
+1,869
+0.9% +$31.2K ﹤0.01% 2532
2023
Q2
$5.51M Buy
199,575
+31,042
+18% +$857K ﹤0.01% 2268
2023
Q1
$3.88M Buy
168,533
+4,208
+3% +$96.8K ﹤0.01% 2440
2022
Q4
$1.79M Buy
164,325
+6,266
+4% +$68.4K ﹤0.01% 2910
2022
Q3
$1.33M Buy
158,059
+15,988
+11% +$135K ﹤0.01% 3066
2022
Q2
$1.12M Buy
142,071
+2,302
+2% +$18.2K ﹤0.01% 3158
2022
Q1
$3.31M Buy
139,769
+1,275
+0.9% +$30.2K ﹤0.01% 2650
2021
Q4
$4.74M Buy
138,494
+7,361
+6% +$252K ﹤0.01% 2491
2021
Q3
$2.32M Sell
131,133
-15,197
-10% -$269K ﹤0.01% 2894
2021
Q2
$6.57M Buy
146,330
+12,735
+10% +$572K ﹤0.01% 2366
2021
Q1
$3.46M Buy
133,595
+4,291
+3% +$111K ﹤0.01% 2627
2020
Q4
$2.61M Buy
129,304
+34,850
+37% +$703K ﹤0.01% 2684
2020
Q3
$1.85M Sell
94,454
-6,898
-7% -$135K ﹤0.01% 2713
2020
Q2
$1.79M Buy
101,352
+17,769
+21% +$314K ﹤0.01% 2746
2020
Q1
$590K Buy
83,583
+1
+0% +$7 ﹤0.01% 3269
2019
Q4
$589K Buy
83,582
+6,180
+8% +$43.6K ﹤0.01% 3507
2019
Q3
$930K Sell
77,402
-26,686
-26% -$321K ﹤0.01% 3213
2019
Q2
$1.26M Buy
104,088
+41,052
+65% +$497K ﹤0.01% 3068
2019
Q1
$792K Sell
63,036
-233
-0.4% -$2.93K ﹤0.01% 3314
2018
Q4
$426K Hold
63,269
﹤0.01% 3566
2018
Q3
$651K Hold
63,269
﹤0.01% 3503
2018
Q2
$426K Buy
63,269
+13,303
+27% +$89.6K ﹤0.01% 3693
2018
Q1
$430K Buy
49,966
+5,493
+12% +$47.3K ﹤0.01% 3638
2017
Q4
$925K Buy
44,473
+15,412
+53% +$321K ﹤0.01% 3288
2017
Q3
$513K Buy
29,061
+1,435
+5% +$25.3K ﹤0.01% 3577
2017
Q2
$313K Buy
27,626
+1,478
+6% +$16.7K ﹤0.01% 3801
2017
Q1
$335K Buy
26,148
+3,433
+15% +$44K ﹤0.01% 3710
2016
Q4
$500K Buy
22,715
+8,513
+60% +$187K ﹤0.01% 3593
2016
Q3
$301K Buy
+14,202
New +$301K ﹤0.01% 3758